Abstract

In 2008, the FDA issued a warning regarding antiepileptic drugs that may cause suicidal tendencies in patients with epilepsy. This statement was received in a rather different way by academics, researchers and clinicians. Specifically, the present review sought to analyze the current situation and knowledge regarding suicidal behavior in people with epilepsy, identifying its prevalence, and the risk factors present in patients. The review is based on scientific papers, published in international data bases. It was found that the prevalence of suicidal conduct in the epileptic patient is diverse but clearly higher than that of the general population. Among the medical risk factors, antiepileptic drugs and the specific type of epilepsy were clearly and widely identified as major predictors of suicidal tendencies. On the other hand, psychological risk factors such as history of mental illness, anxiety, depression and previous suicide attempts proved to be the most significant. There are, clearly, fewer social and cultural risk factors, and their link with suicide is still a matter of controversy. Evidence shows that suicide happens in epilepsy patients. These people must be of the upmost concern for all healthcare professionals and providers.
Original languageSpanish
Pages (from-to)260 - 271
Number of pages11
JournalActa Neurológica Colombiana
Volume32
Issue number3
DOIs
StatePublished - 2016

Cite this

@article{c90b4a12e8484b8990645377f6fce67d,
title = "Epilepsia y suicidio: una revisi{\'o}n del tema",
abstract = "In 2008, the FDA issued a warning regarding antiepileptic drugs that may cause suicidal tendencies in patients with epilepsy. This statement was received in a rather different way by academics, researchers and clinicians. Specifically, the present review sought to analyze the current situation and knowledge regarding suicidal behavior in people with epilepsy, identifying its prevalence, and the risk factors present in patients. The review is based on scientific papers, published in international data bases. It was found that the prevalence of suicidal conduct in the epileptic patient is diverse but clearly higher than that of the general population. Among the medical risk factors, antiepileptic drugs and the specific type of epilepsy were clearly and widely identified as major predictors of suicidal tendencies. On the other hand, psychological risk factors such as history of mental illness, anxiety, depression and previous suicide attempts proved to be the most significant. There are, clearly, fewer social and cultural risk factors, and their link with suicide is still a matter of controversy. Evidence shows that suicide happens in epilepsy patients. These people must be of the upmost concern for all healthcare professionals and providers.",
author = "{Palacios Sanchez}, Leonardo and {Palacios Espinosa}, Ximena",
year = "2016",
doi = "10.22379/issn.2422-4022",
language = "Espa{\~n}ol",
volume = "32",
pages = "260 -- 271",
journal = "Acta Neurol{\'o}gica Colombiana",
issn = "0120-8748",
publisher = "Editorial Asociaci{\'o}n Colombiana de Neurolog{\'i}a ",
number = "3",

}

Epilepsia y suicidio: una revisión del tema. / Palacios Sanchez, Leonardo; Palacios Espinosa, Ximena.

In: Acta Neurológica Colombiana, Vol. 32, No. 3, 2016, p. 260 - 271.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Epilepsia y suicidio: una revisión del tema

AU - Palacios Sanchez, Leonardo

AU - Palacios Espinosa, Ximena

PY - 2016

Y1 - 2016

N2 - In 2008, the FDA issued a warning regarding antiepileptic drugs that may cause suicidal tendencies in patients with epilepsy. This statement was received in a rather different way by academics, researchers and clinicians. Specifically, the present review sought to analyze the current situation and knowledge regarding suicidal behavior in people with epilepsy, identifying its prevalence, and the risk factors present in patients. The review is based on scientific papers, published in international data bases. It was found that the prevalence of suicidal conduct in the epileptic patient is diverse but clearly higher than that of the general population. Among the medical risk factors, antiepileptic drugs and the specific type of epilepsy were clearly and widely identified as major predictors of suicidal tendencies. On the other hand, psychological risk factors such as history of mental illness, anxiety, depression and previous suicide attempts proved to be the most significant. There are, clearly, fewer social and cultural risk factors, and their link with suicide is still a matter of controversy. Evidence shows that suicide happens in epilepsy patients. These people must be of the upmost concern for all healthcare professionals and providers.

AB - In 2008, the FDA issued a warning regarding antiepileptic drugs that may cause suicidal tendencies in patients with epilepsy. This statement was received in a rather different way by academics, researchers and clinicians. Specifically, the present review sought to analyze the current situation and knowledge regarding suicidal behavior in people with epilepsy, identifying its prevalence, and the risk factors present in patients. The review is based on scientific papers, published in international data bases. It was found that the prevalence of suicidal conduct in the epileptic patient is diverse but clearly higher than that of the general population. Among the medical risk factors, antiepileptic drugs and the specific type of epilepsy were clearly and widely identified as major predictors of suicidal tendencies. On the other hand, psychological risk factors such as history of mental illness, anxiety, depression and previous suicide attempts proved to be the most significant. There are, clearly, fewer social and cultural risk factors, and their link with suicide is still a matter of controversy. Evidence shows that suicide happens in epilepsy patients. These people must be of the upmost concern for all healthcare professionals and providers.

U2 - 10.22379/issn.2422-4022

DO - 10.22379/issn.2422-4022

M3 - Artículo

VL - 32

SP - 260

EP - 271

JO - Acta Neurológica Colombiana

JF - Acta Neurológica Colombiana

SN - 0120-8748

IS - 3

ER -